Filing status
- Accounts due
- 30 June 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 13 May 2027
- Last conf. stmt
- 29 April 2026
Glaxosmithkline Finance PLC
- Incorporated
- 2 October 1929 (97 years)
- Industry
- Financial intermediation not elsewhere classified (64999)
- Directors
- Owned by
- Accounts type
- Full
- Region
- Greater London
- Address
- 79 New Oxford StreetLondonWC1A 1DG
Charges
- Total
- 1
- Outstanding
- 1
- Part satisfied
- 0
- Satisfied
- 0
Officers 5 active
Officer details are public data from the Companies House register.
Director · Appointed 11 February 2019
British
Born November 1967
Corporate Director · Appointed 5 March 2007
Secretary · Appointed 18 January 2002
British
Corporate Director · Appointed 28 February 2001
Corporate Director · Appointed 28 February 2001
Officer history (16 former)
1 May 2019
11 February 2019
11 February 2019
10 March 2014
Resigned Bicknell, Simon as Secretary
30 July 2013
Appointed Bicknell, Simon as Secretary
1 December 2011
1 April 2011
31 March 2011
9 September 2009
5 March 2007
18 January 2002
18 January 2002
1 March 2001
1 March 2001
1 March 2001
28 February 2001
28 February 2001
28 February 2001
27 December 2000
20 December 1999
20 December 1999
1 January 1999
31 December 1998
4 September 1998
4 September 1998
4 September 1998
11 April 1994
11 April 1994
1 January 1994
1 January 1994
1 January 1994
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Limited Company
Reg. no. 05647873
Group structure 22 shown
Ownership group derived from the Companies House PSC register
British Pharma Group Limited Holds 25–50% of voting rights
Glaxosmithkline Holdings (One) Limited Owns 75–100% of shares
Glaxosmithkline Holdings Limited Owns 75–100% of shares
Glaxosmithkline Finance PLC This company Owns 75–100% of shares
Glaxo Group Limited Owns 75–100% of shares
Glaxosmithkline Ihc Limited Owns 75–100% of shares
GSK Finance (No 2) Limited Owns 75–100% of shares
Setfirst Limited Owns 75–100% of shares
Smithkline Beecham Limited Owns 75–100% of shares
Wellcome Limited Owns 75–100% of shares
Glaxosmithkline Mercury Limited Owns 75–100% of shares
Viiv Healthcare Limited Owns 75–100% of shares
Viiv Healthcare Finance 2 Limited Owns 75–100% of shares
Viiv Healthcare Overseas Limited Owns 75–100% of shares
Viiv Healthcare Trading Services UK Limited Owns 75–100% of shares
Viiv Healthcare UK (No.4) Limited Owns 75–100% of shares
Viiv Healthcare UK (No.5) Limited Owns 75–100% of shares
Viiv Healthcare UK (No.6) Limited Owns 75–100% of shares
Viiv Healthcare UK (No.7) Limited Owns 75–100% of shares
Viiv Healthcare UK Limited Owns 75–100% of shares
Glaxosmithkline Services Unlimited Owns 75–100% of shares
Filings 217
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 14 July 2026 | Full accounts | 31 December 2025 | ||
| 29 April 2026 | Confirmation statement with no updates | 29 April 2026 | ||
| 15 February 2026 | Statement of company's objects | |||
| 28 January 2026 | Memorandum and Articles of Association | |||
| 28 January 2026 | Resolutions |
Some other companies at this address
Other companies in this industry
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →